Targeting maternal immune function during pregnancy for asthma prevention in offspring: Harnessing the “farm effect”? - 05/08/20
Doi : 10.1016/j.jaci.2020.04.008
Patrick G. Holt, DSc, FAA a, ⁎ 
, Deborah H. Strickland, PhD a, Adnan Custovic, MD, PhD b
, Deborah H. Strickland, PhD a, Adnan Custovic, MD, PhD b a Telethon Kids Institute, The University of Western Australia, Nedlands, Australia
b National Heart and Lung Institute, Imperial College London, London, United Kingdom
∗Corresponding author: Patrick G. Holt, DSc, FAA, Telethon Kids Institute, Northern Entrance, Perth Children’s Hospital, 15 Hospital Ave, Nedlands, WA 6009, Australia.Telethon Kids InstituteNorthern EntrancePerth Children’s Hospital15 Hospital AveNedlandsWA6009Australia
Key words : Asthma prevention, maternal infection, maternal immune training, maternal (fetal) benefit, transplacental effects, OM85-bronchovaxom
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 146 - N° 2
P. 270-272 - Agosto 2020 Ritorno al numero
Articolo precedente
- Cost considerations for clinicians prescribing biologic drugs: Who pays?
- Christopher Hvisdas, Patrick K. Gleeson, Andrea J. Apter
- Active control of mucosal tolerance and inflammation by human IgA and IgG antibodies
- Willianne Hoepel, Korneliusz Golebski, Cornelis M. van Drunen, Jeroen den Dunnen
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?